-
Je něco špatně v tomto záznamu ?
Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases
A. Cinkajzlová, M. Mráz, M. Haluzík
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Free Medical Journals
od 1997-09-01 do Před 1 rokem
Open Access Digital Library
od 1939-01-01
Open Access Digital Library
od 1997-09-01
PubMed
34592714
DOI
10.1530/joe-21-0159
Knihovny.cz E-zdroje
- MeSH
- cytokiny metabolismus MeSH
- diabetes mellitus 2. typu imunologie metabolismus MeSH
- imunitní systém metabolismus fyziologie MeSH
- kardiovaskulární nemoci etiologie imunologie metabolismus MeSH
- lidé MeSH
- makrofágy patologie fyziologie MeSH
- obezita imunologie metabolismus MeSH
- rizikové faktory MeSH
- tuková tkáň imunologie metabolismus MeSH
- zánět imunologie metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Immune cells are an inseparable component of adipose tissue intimately involved in most of its functions. Physiologically, they regulate adipose tissue homeostasis, while in case of adipose tissue stress, immune cells are able to change their phenotype, enhance their count and subsequently contribute to the development and maintenance of local adipose tissue inflammation. Immune cells are an important source of inflammatory cytokines and other pro-inflammatory products that further influence not only surrounding tissues but via systemic circulation also the whole organism being thus one of the main factors responsible for the transition from simple obesity to associated metabolic and cardiovascular complications. The purpose of this review is to summarize current knowledge on different adipose tissue immune cell subsets and their role in the development of obesity, type 2 diabetes mellitus and cardiovascular diseases.
Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Experimental Medicine Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003170
- 003
- CZ-PrNML
- 005
- 20220127150616.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1530/JOE-21-0159 $2 doi
- 035 __
- $a (PubMed)34592714
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Cinkajzlová, Anna $u Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
- 245 10
- $a Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases / $c A. Cinkajzlová, M. Mráz, M. Haluzík
- 520 9_
- $a Immune cells are an inseparable component of adipose tissue intimately involved in most of its functions. Physiologically, they regulate adipose tissue homeostasis, while in case of adipose tissue stress, immune cells are able to change their phenotype, enhance their count and subsequently contribute to the development and maintenance of local adipose tissue inflammation. Immune cells are an important source of inflammatory cytokines and other pro-inflammatory products that further influence not only surrounding tissues but via systemic circulation also the whole organism being thus one of the main factors responsible for the transition from simple obesity to associated metabolic and cardiovascular complications. The purpose of this review is to summarize current knowledge on different adipose tissue immune cell subsets and their role in the development of obesity, type 2 diabetes mellitus and cardiovascular diseases.
- 650 _2
- $a tuková tkáň $x imunologie $x metabolismus $7 D000273
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kardiovaskulární nemoci $x etiologie $x imunologie $x metabolismus $7 D002318
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a diabetes mellitus 2. typu $x imunologie $x metabolismus $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunitní systém $x metabolismus $x fyziologie $7 D007107
- 650 _2
- $a zánět $x imunologie $x metabolismus $7 D007249
- 650 _2
- $a makrofágy $x patologie $x fyziologie $7 D008264
- 650 _2
- $a obezita $x imunologie $x metabolismus $7 D009765
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mráz, Miloš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Haluzík, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 773 0_
- $w MED00002653 $t The Journal of endocrinology $x 1479-6805 $g Roč. 252, č. 1 (2021), s. R1-R22
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34592714 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150613 $b ABA008
- 999 __
- $a ok $b bmc $g 1750819 $s 1154319
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 252 $c 1 $d R1-R22 $e 20211124 $i 1479-6805 $m Journal of Endocrinology $n J Endocrinol $x MED00002653
- LZP __
- $a Pubmed-20220113